Monica Shokeen, MBA, PhD

Medical School Department Radiology
Research Program Oncologic Imaging
Monica Shokeen

Researcher Background

Primary Academic Title

Associate Professor of Radiology, WashU Medicine

Training

  • 2006 - 2009: Postdoctoral Fellow, Radiochemistry, Washington University, St. Louis, MO

Education

  • 1999: MBA, International Business, Kurukshetra University, Haryana, India
  • 2006: PhD, Inorganic Chemistry, Washington University, St. Louis, MO

Research & Selected Publications

Research Interest

The evaluation of small molecule and macromolecular agents for molecular imaging and drug delivery for cancer; The evaluation of novel nanoparticle constructs for molecular imaging and targeted drug delivery.

Research Publications

On-Resin DIAMSAR-Conjugated CD38-Targeted Peptides and Their Inverso and Dimeric-Inverso Analogs for PET Imaging of Multiple Myeloma.
Authors:

Sharma AK, Tang R, Zheleznyak A, one or more additional authors omitted Shokeen M

Journal & Year:

Bioconjug Chem • 2026

Ablation of CD38 in multiple myeloma cells leads to an aggressive phenotype in a mouse xenograft model.
Authors:

Dyer MR, Zheleznyak A, Teubner EN, one or more additional authors omitted Shokeen M

Journal & Year:

Blood Adv • 2026

Advanced quantification pipeline reveals new spatial and temporal tumor characteristics in preclinical multiple myeloma.
Authors:

Sun Z, Godbe JM, Zheleznyak A, one or more additional authors omitted Shokeen M

Journal & Year:

EJNMMI Res • 2025

Advanced Quantification Pipeline Reveals New Spatial and Temporal Tumor Characteristics in Preclinical Multiple Myeloma.
Authors:

Sun Z, Godbe J, Zheleznyak A, one or more additional authors omitted Shokeen M

Journal & Year:

Res Sq • 2025

Correction: Tissue biodistribution and tumor targeting of near-infrared labelled anti-CD38 antibody-drug conjugate in preclinical multiple myeloma.
Authors:

Cho N, Ko S, Shokeen M

Journal & Year:

Oncotarget • 2025

Chemo-RaST with bortezomib inhibits multiple myeloma relapse.
Authors:

Ghai A, Zheleznyak A, Egbulefu C, one or more additional authors omitted Shokeen M, Achilefu S

Journal & Year:

Theranostics • 2025

Cancer-targeted pro-theranostic bi-metallic organo-coordination nanoparticles.
Authors:

Huang H, Fang L, Wansapura J, one or more additional authors omitted Shokeen M, one or more additional authors omitted Achilefu S

Journal & Year:

Theranostics • 2025

IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma.
Authors:

Sun J, Corradini S, Azab F, Shokeen M, one or more additional authors omitted Azab AK

Journal & Year:

Leukemia • 2024